USA Based CIPRA.ai Expands its Precision Chronic Care Services to India, Partners with RxDx, 2050 Healthcare, and ARTPARK @IISc Bangalore
SAN FRANCISCO, Feb. 15, 2024 /PRNewswire-PRWeb/ -- San Diego, California based leading health technology platform CIPRA.ai has announced the launch of its personalized services in India and a strategic partnership with renowned healthcare providers in the industry - RxDx and 2050 Healthcare and innovation partner ARTPARK @IISc Bangalore. The Bengaluru based RxDx, a NABH and NABL-accredited multispeciality healthcare chain, and 2050 Healthcare, a leading healthcare provider specializing in rehabilitation and home healthcare, will help CIPRA.ai expand its presence in India. ARTPARK @IISc Bangalore, a leading AI and robotics accelerator backed by the Indian Institute of Science, has become CIPRA.ai's innovation partner to help it scale growth objectives and achieve its first 10K patients by 2024. The primary goal of the partnership is to help address gaps in conventional care and capacitate patients and physicians to control and reverse chronic diseases using AI and data-driven precision care in India. Through collective efforts, CIPRA.ai also aims to become a health tool that enables healthcare providers to expand clinical capacities.
- CIPRA.ai has launched its health services in India to help patients combat chronic conditions through personalized and proactive care.
- CIPRA.ai's subscription services are designed to offer precise and personalized patient care treating and reversing chronic conditions such as diabetes and hypertension.
- Before launching services in India, CIPRA.ai has been successfully delivering hypertension and diabetes services in the USA since 2022.
- CIPRA.ai plans to expand its focus beyond hypertension and diabetes to offer data-based precision care to more chronic diseases.